141 related articles for article (PubMed ID: 36736346)
1. Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis.
Lieb S; Heni M; Rauschenberg S; Lange K; Feisthammel J; Bläker H; Wiegand J
Z Gastroenterol; 2023 Nov; 61(11):1500-1503. PubMed ID: 36736346
[TBL] [Abstract][Full Text] [Related]
2. Histologic manifestations of ocrelizumab-associated intestinal and hepatic injury in patients with multiple sclerosis.
Challa B; Esnakula AK
Histopathology; 2024 Apr; 84(5):765-775. PubMed ID: 38114289
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Rapid Desensitization to Ocrelizumab for Multiple Sclerosis Is Effective and Safe.
Aun MV; Freua F; Marussi VHR; Giavina-Bianchi P
Front Immunol; 2022; 13():840238. PubMed ID: 35222433
[TBL] [Abstract][Full Text] [Related]
4. Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab.
Clerico M; De Mercanti S; Artusi CA; Durelli L; Naismith RT
Mult Scler; 2017 May; 23(6):874-876. PubMed ID: 28290755
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD20 monoclonal antibody (mAb) therapy and colitis: A case series and review.
Tolaymat S; Sharma K; Kagzi Y; Sriwastava S
Mult Scler Relat Disord; 2023 Jul; 75():104763. PubMed ID: 37229799
[TBL] [Abstract][Full Text] [Related]
6. Dengue fever in a multiple sclerosis patient taking Ocrelizumab.
Guerra T; Bollo L; Trojano M; Iaffaldano P
Mult Scler; 2021 Nov; 27(13):2116-2118. PubMed ID: 34449289
[TBL] [Abstract][Full Text] [Related]
7. CMV coinfection in treatment refractory immune checkpoint inhibitor colitis.
Harris KB; Funchain P; Baggott BB
BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32434876
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus colitis complicating inflammatory bowel disease.
Kandiel A; Lashner B
Am J Gastroenterol; 2006 Dec; 101(12):2857-65. PubMed ID: 17026558
[TBL] [Abstract][Full Text] [Related]
9. Viral pericarditis following ocrelizumab in a multiple sclerosis patient.
Miele G; Abbadessa G; Maida E; Bonavita S
Neurol Sci; 2023 Aug; 44(8):2947-2949. PubMed ID: 37095363
[TBL] [Abstract][Full Text] [Related]
10. First Case of Refractory Colitis Caused by Ocrelizumab.
Sunjaya DB; Taborda C; Obeng R; Dhere T
Inflamm Bowel Dis; 2020 May; 26(6):e49. PubMed ID: 32198886
[No Abstract] [Full Text] [Related]
11. Cytomegalovirus colitis in a patient with Behcet's disease receiving tumor necrosis factor alpha inhibitory treatment.
Sari I; Birlik M; Gonen C; Akar S; Gurel D; Onen F; Akkoc N
World J Gastroenterol; 2008 May; 14(18):2912-4. PubMed ID: 18473420
[TBL] [Abstract][Full Text] [Related]
12. Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.
Auer M; Bsteh G; Hegen H; Wurth S; Zinganell A; Berger T; Deisenhammer F; Pauli FD
Mult Scler Relat Disord; 2020 Aug; 43():102155. PubMed ID: 32470856
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus esophagitis in a patient on ocrelizumab therapy: A case report.
Miller AA; Mathew D; Huot C
Am J Health Syst Pharm; 2020 Aug; 77(16):1278-1279. PubMed ID: 32766728
[No Abstract] [Full Text] [Related]
14. Babesia microti infection in a patient with multiple sclerosis treated with ocrelizumab.
Haberli N; Coban H; Padam C; Montezuma-Rusca JM; Creed MA; Imitola J
Mult Scler Relat Disord; 2021 Feb; 48():102731. PubMed ID: 33450528
[TBL] [Abstract][Full Text] [Related]
15. Ocrelizumab: its efficacy and safety in multiple sclerosis.
Juanatey A; Blanco-Garcia L; Tellez N
Rev Neurol; 2018 Jun; 66(12):423-433. PubMed ID: 29897610
[TBL] [Abstract][Full Text] [Related]
16. Acute CMV-colitis in a patient with a history of ulcerative colitis.
Streetz KL; Buhr T; Wedemeyer H; Bleck J; Schedel I; Manns MP; Göke MN
Scand J Gastroenterol; 2003 Jan; 38(1):119-22. PubMed ID: 12608474
[TBL] [Abstract][Full Text] [Related]
17. [Ocrelizumab for treatment of multiple sclerosis].
Graf J; Albrecht P; Goebels N; Aktas O; Hartung HP
Nervenarzt; 2020 Aug; 91(8):722-734. PubMed ID: 32524163
[TBL] [Abstract][Full Text] [Related]
18. Ocrelizumab: A Review in Multiple Sclerosis.
Lamb YN
Drugs; 2022 Feb; 82(3):323-334. PubMed ID: 35192158
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus Colitis: An Uncommon Mimicker of Common Colitides.
Baniak N; Kanthan R
Arch Pathol Lab Med; 2016 Aug; 140(8):854-8. PubMed ID: 27472242
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus colitis in patients without inflammatory bowel disease: a single center study.
Kim CH; Bahng S; Kang KJ; Ku BH; Jo YC; Kim JY; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC; Kim YH
Scand J Gastroenterol; 2010 Nov; 45(11):1295-301. PubMed ID: 20568970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
